What is HER2?
HER2 stands for human epidermal growth factor receptor 2. It is a protein found on the surface of some cells, and it helps cells grow and divide. The HER2 test checks how much of this protein, or how many copies of its gene, a tumour sample carries.
HER2 testing is most often done for breast cancer, but it is also done for some other cancers, such as certain stomach and gastro-oesophageal cancers. Knowing the result helps the oncologist understand the cancer better and discuss treatment options. On its own, though, it is one detail in a larger picture that also includes the cancer type, stage and other tests.
How the HER2 test is done: IHC and FISH
The test is usually done on tissue taken during a biopsy or surgery, and it is read by a pathologist, the doctor who studies tissue under a microscope. Two laboratory methods are used.
Often IHC is done first. If the IHC score is clear, the result may be reported as it is. If the score falls in an in-between group, the lab may run FISH on the same sample for a clearer answer. Reports use different wording, such as scores written with a plus sign, so the same result can look different from one lab to another. Ask which method was used for yours.
- IHC, immunohistochemistry: a stain shows how much HER2 protein is on the cells
- FISH, fluorescence in situ hybridisation: counts copies of the HER2 gene
What a HER2-positive result can mean
A HER2-positive result usually means the tumour sample has more HER2 protein, or more copies of the HER2 gene, than usual. It describes a feature of the tumour. It does not say how serious the cancer is, and it is not a good or bad sign by itself.
HER2-positive cancers can behave differently from HER2-negative ones, and medicines aimed at HER2 exist. Whether any such medicine is discussed for a particular person depends on the cancer type, its stage, other test results and overall health, so only the oncologist can say. Ask which test gave the result, whether it needs to be confirmed, and how it fits with the rest of your reports.
What a HER2-negative result can mean
A HER2-negative result usually means the tumour sample does not have extra HER2 protein or extra copies of the HER2 gene. Like a positive result, it describes the tumour; it is not a judgement on how the cancer will behave.
HER2-negative breast cancers are still treated, and many treatment options exist. Which ones are discussed depends on other details in the report, such as hormone receptor results, the stage, the grade and the person's general health. Sometimes a result falls in a borderline or unclear group, and another test may be suggested. Ask your oncologist to go through the HER2 line with you and explain what it changes, and what it does not.
What HER2-low means
HER2-low is a newer way of describing tumours that have a small amount of HER2 protein, but not enough to be called HER2-positive. In older reports, these tumours are usually grouped under HER2-negative, which is why the term can feel confusing.
HER2-low is not a separate type of cancer. It describes a test result, usually from the IHC method, where the lab gives a score based on how strongly the cells stain. Doctors have begun to pay attention to this group because research is still looking at whether some medicines may help people whose tumours show a little HER2. Whether it matters for you depends on the cancer type and the rest of the report.
Questions to ask your oncologist
Carry a copy of the full report to every visit, so the doctor can see the exact wording and the method used. A cancer is not always the same all through, so results from a biopsy and a later surgery sample, or from two labs, can sometimes differ. If you have more than one HER2 result, keep all the reports together and show them.
Write your questions down before the visit. Your oncologist explains what your result means for you.
- Which test gave this result, IHC or FISH?
- Does the result need to be confirmed or repeated?
- Does HER2-low or a low score affect the options being discussed?
- If I have two results, which one do you rely on?
- How does this fit with the rest of my reports?
Find HER2 in your report with OncoVOIS
HER2 usually appears in the pathology or biopsy report, often in a section on biomarkers, receptor status or special tests. It may be written as HER2, HER2/neu, ERBB2, or as an IHC score or FISH result. Lab reports vary, so it can be hard to spot.
With OncoVOIS, you add a report with your camera, a photo, a PDF or a Word file. The app reads it and shows what it found, and you check it before anything is saved. The summary explains hard words in plain language, and the Cancer profile gathers details such as markers in one place, showing which report each came from. The app does not tell you what a result means for you; take that question to your oncologist.